Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis

Published:2018-08 Issue: Volume:34 Page:94-107
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Chen Zhicong^ORCID,Zhan Yonghao,Chi Jieshan,Guo Shuyuan,Zhong Xinliang,He Anbang,Zheng Jianrong,Gong Yanqing,Li Xuesong,Zhou Liqun

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Natural Science Foundation of Beijing

Peking University Health Science Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference68 articles.

1. Methodological challenges in the evaluation of prognostic factors in breast cancer;Altman;Breast Cancer Res. Treat.,1998

2. Prognostic factors for renal cell carcinoma;Furniss;Cancer Treat. Rev.,2008

3. Prognostic and prediction tools in bladder Cancer: a comprehensive review of the literature;Kluth;Eur. Urol.,2015

4. Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications;Terada;Ther Adv Med Oncol,2017

5. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis;Louie;Ann. Oncol.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets;Annals of Surgical Oncology;2024-05-17

2. MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer;Cancers;2023-02-17

3. The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach;Cancers;2022-11-03

4. Regulatory RNAs in the molecular pathology of neoplasia;SCIENTIA SINICA Vitae;2022-10-11

5. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer;Clinical and Translational Oncology;2022-01-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3